Artificial Pancreas Device System Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
The artificial pancreas device system market is projected to reach US$ 3,585.75 million by 2031 from US$ 1,190.23 million in 2022; it is estimated to grow at a CAGR of 20.28% from 2022–2031.
Artificial pancreas device systems closely copy the glucose-regulating function of the fit pancreas. The device not only monitors the glucose levels in the body but also automatically adjusts the distribution of insulin to reduce blood glucose levels and lowers the incidence of low blood glucose with less or no input from patients. According to the Food and Drug Administration, the use of an artificial pancreas is associated with better control of blood sugar levels for people with type 1 diabetes compared with standard treatment.
The artificial pancreas device system market is segmented on the basis of type and geography. Based on geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The report offers insights and in-depth analysis of the market, emphasizing on parameters such as market trends, technological advancements, and market dynamics, along with the analysis of the competitive landscape of the globally leading market players.
Strategic Insights
Market Insights
Growing Prevalence of Diabetes Bolsters Artificial Pancreas Device System Market
Diabetes is a life-threatening chronic disease with no specialized cure. The disease is mainly caused by the body’s inability to produce or effectively utilize the hormone insulin. It is one of the largest global health emergencies of the 21st century. Diabetes prevents the body from adequately regulating blood glucose levels. There are two types of diabetes, namely, diabetes type-I (also known as diabetes insipidus) and diabetes type II (also termed diabetes mellitus). Obesity, a sedentary lifestyle, and unhealthy eating habits are the key risk factors that are associated with the rapidly increasing diabetic population.
According to the International Diabetes Federation (IDF), in North America, the number of people with diabetes is expected to rise from ~46 million in 2017 to ~62 million by 2045; the disease prevalence is likely to surge by ~35% during the forecast period. According to the American Diabetes Association, ~30.3 million people, i.e., up to 9.4% of the US population, suffered from diabetes; out of this, 1.25 million children suffered from diabetes type I, in 2017. The National Institutes of Health also states that the incidence of diabetes type I is increasing rapidly worldwide, affecting a significant number of children and teenagers. According to the same source, ~84 million people in Southeast Asia suffer from diabetes in 2017. Out of these patients, 149,300 children suffer from diabetes type-I and require a daily dosage of insulin shots. Type 2 diabetes is the most prevalent form of diabetes, and has increased alongside cultural and societal changes. In high-income countries, up to 91% of diabetic adults have type 2 diabetes. According to the IDF, ~425 million people in the world were living with diabetes in 2017, and the number is expected to reach 629 million by 2045.
Diabetes of all types can lead to various complications in many parts of the body and can increase the overall risk of premature death. Heart attack, stroke, kidney failure, leg amputation, vision loss, and nerve damage are the major complications associated with this disease. Patients suffering from diabetes require frequent monitoring and external insulin administration.
Type Insights
Based on type, the artificial pancreas device system market is segmented into control to range, control to target and threshold suspended device systems. In 2022, the threshold-suspended device systems segment held the largest share of the market. The segment is further expected to register the highest CAGR during 2022–2031. With threshold suspend device systems, also called low glucose suspend systems, the delivery of insulin is suspended for a set time when 2 glucose levels are below a specified low level, indicating hypoglycemia. A threshold-suspended device helps reverse the drop in blood glucose levels. With threshold suspend device systems, also called low glucose suspend systems, the delivery of insulin is suspended for a set time when 2 glucose levels are below a specified low level. Threshold-suspended devices cannot respond to a low blood sugar (hypoglycemic) event.
Product launches and mergers and acquisitions are the highly adopted strategies by companies operating in the global artificial pancreas device system market. A few of the recent key product developments are listed below:
- In June 2021, Medtronic received CE mark for the MiniMed 780G system to cure type 1 diabetes patients from the age group 7 to 80 years of age.
- In April 2022, Abbott collaborated with Ypsomed, CamDiab to bring artificial pancreas system to Europe.
- In January 2021, Medtronic launched its MiniMed 780G system in UK. It is an advanced hybrid closed-loop insulin delivery system that is used for the management of type 1 diabetes for people aged 7 to 80 years.
Artificial Pancreas Device System Market – Market Segmentation
In terms of type, the artificial pancreas device system market is segmented into control to range, control to target, and threshold suspended device systems. Based on Geography, the market is divided into North America (US, Canada, Mexico), Europe (France, Germany, UK, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific), Middle East & Africa (Saudi Arabia, South Africa, UAE, and Rest of Middle East & Africa), South and Central America (Brazil, Argentina, and Rest of South and Central America)
Company Profiles
- Defymed
- Typezero Technologies, Inc
- Insulet Corporation
- Bigfoot Biomedical, Inc
- Medtronic
- Dexcom, Inc
- Admetsys
- Beta Bionics
- Cellnovo
- Tandem Diabetes Care, Inc
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
TABLE OF CONTENTS
1. INTRODUCTION 16
1.1 SCOPE OF THE STUDY 16
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 16
2. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET – KEY TAKEAWAYS 17
3. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET – MARKET LANDSCAPE 19
3.1 OVERVIEW 19
3.2 MARKET SEGMENTATION 19
3.2.1 Global Artificial pancreas device systems Market – By Type 20
3.2.2 Global Artificial pancreas device systems Market – By Geography 20
3.3 PEST ANALYSIS 22
3.3.1 North America – PEST Analysis 22
3.3.2 Europe– PEST Analysis 24
3.3.3 Asia Pacific– PEST Analysis 26
3.3.4 Middle East And Africa– PEST Analysis 28
3.3.5 South and Central America – PEST Analysis 30
4. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET – KEY MARKET DYNAMICS 32
4.1 KEY MARKET DRIVERS 32
4.1.1 Growing Prevalence of Diabetes 32
4.1.2 Developments by Major Players 33
4.1.3 Rise in Demand for Computerized Systems for Glycemic Control 34
4.2 KEY MARKET RESTRAINTS 35
4.2.1 Availability of Alternatives for Artificial Pancreas Device Systems 35
4.2.2 High Cost of Artificial Pancreas Device Systems 36
4.3 KEY MARKET OPPORTUNITIES 36
4.3.1 Increasing Medical Tourism In Emerging Nations 36
4.4 FUTURE TRENDS 36
4.4.1 Pancreas Cell Implant 37
4.5 IMPACT ANALYSIS 38
5. ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET – GLOBAL ANALYSIS 39
5.1 GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE FORECASTS AND ANALYSIS 39
5.2 GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS 40
5.3 PROMINENT PLAYERS IN THE MARKET 41
5.3.1 Medtronic 41
5.3.2 Insulet Corporation 41
5.3.3 Tandem Diabetes Care, Inc. 42
5.4 EXPERT OPINIONS 42
6. GLOBAL ARTIFICIAL PANCREAS DEVICES SYSTEMS ANALYSIS – BY TYPE 43
6.1 OVERVIEW 43
6.2 GLOBAL ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY TYPE, 2017 & 2025 (%) 43
6.3 CONTROL TO RANGE MARKET 44
6.3.1 Overview 44
6.3.2 Global Control to Range Market Revenue and Forecasts to 2025 (US$ Mn) 44
6.4 CONTROL TO TARGET MARKET 45
6.4.1 Overview 45
6.4.2 Global Control to Target Market Revenue and Forecasts to 2025 (US$ Mn) 45
6.5 THRESHOLD SUSPENDED DEVICE SYSTEM MARKET 46
6.5.1 Overview 46
6.5.2 Global Threshold Suspended Device System Market Revenue and Forecasts to 2025 (US$ Mn) 46
7. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 47
7.1 OVERVIEW 47
7.2 NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 48
7.3 NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 48
7.4 NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 49
7.5 US ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 50
7.6 US ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 51
7.6.1 US Artificial Pancreas Device Systems Market Revenue And Forecasts to 2025, By Type (US$ Mn) 51
7.7 CANADA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 52
7.8 CANADA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 52
7.8.1 Canada Artificial Pancreas Device Systems Market Revenue And Forecasts to 2025, By Type (US$ Mn) 53
7.9 MEXICO ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 54
7.10 MEXICO ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 54
7.10.1 Mexico Artificial Pancreas Device Systems Market Revenue And Forecasts to 2025, By Type (US$ Mn) 55
8. EUROPE ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 56
8.1 OVERVIEW 56
8.2 EUROPE ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 57
8.3 EUROPE ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 57
8.4 EUROPE ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 58
8.5 GERMANY ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 59
8.5.1 Germany Artificial Pancreas Device Systems Market Revenue and Forecasts To 2025 (US$ Mn) 60
8.5.2 Germany Artificial Pancreas Device Systems Market Revenue And Forecasts to 2025, By Type (US$ Mn) 60
8.6 UK ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 61
8.6.1 UK Artificial Pancreas Device Systems Market Revenue and Forecasts To 2025 (US$ Mn) 61
8.6.2 UK Artificial Pancreas Device Systems Market Revenue And Forecasts to 2025, By Type (US$ Mn) 62
8.7 FRANCE ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 63
8.7.1 France Artificial Pancreas Device Systems Market Revenue and Forecasts To 2025 (US$ Mn) 63
8.7.2 France Artificial Pancreas Device Systems Market Revenue And Forecasts to 2025, By Type (US$ Mn) 64
9. ASIA PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 65
9.1 OVERVIEW 65
9.2 ASIA PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 66
9.3 ASIA PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 66
9.4 ASIA PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (US$ MN) 67
9.5 JAPAN ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 68
9.6 JAPAN ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 69
9.6.1 Japan Artificial Pancreas Device Systems Market Revenue And Forecasts to 2025, By Type (US$ Mn) 69
9.7 CHINA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 70
9.8 CHINA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 70
9.8.1 China Artificial Pancreas Device Systems Market Revenue And Forecasts to 2025, By Type (US$ Mn) 71
9.9 INDIA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 72
9.10 INDIA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 73
9.10.1 India Artificial Pancreas Device Systems Market Revenue And Forecasts to 2025, By Type (US$ Mn) 73
10. MIDDLE EAST AND AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 74
10.1 OVERVIEW 74
10.2 MIDDLE EAST AND AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 75
10.3 MIDDLE EAST AND AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 75
10.4 MIDDLE EAST AND AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (US$ MN) 76
10.5 UAE ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 77
10.6 UAE ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 78
10.6.1 UAE Artificial Pancreas Device Systems Market Revenue And Forecasts to 2025, By Type (US$ Mn) 78
10.7 SAUDI ARABIA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 79
10.8 SAUDI ARABIA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 80
10.8.1 Saudi Arabia Artificial Pancreas Device Systems Market Revenue And Forecasts to 2025, By Type (US$ Mn) 80
10.9 SOUTH AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 81
10.10 SOUTH AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 82
10.10.1 South Africa Artificial Pancreas Device Systems Market Revenue And Forecasts to 2025, By Type (US$ Mn) 82
11. SOUTH AND CENTRAL AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 83
11.1 OVERVIEW 83
11.2 SOUTH AND CENTRAL AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 84
11.3 SOUTH AND CENTRAL AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 84
11.4 SOUTH AND CENTRAL AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET SHARE, BY COUNTRY (2017 & 2025) (%) 85
11.5 BRAZIL ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 86
11.5.1 Brazil Artificial Pancreas Device Systems Market Revenue And Forecasts to 2025 (US$ Mn) 86
11.5.2 Brazil Artificial Pancreas Device Systems Market Revenue And Forecasts to 2025, By Type (US$ Mn) 86
12. ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET –INDUSTRY LANDSCAPE 88
12.1 OVERVIEW 88
12.2 GROWTH STRATEGIES IN THE ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET, 2016-2018 88
12.3 ORGANIC GROWTH STRATEGIES 89
12.3.1 Overview 89
12.3.2 Product Approval 89
12.3.3 Product Launch 90
12.3.4 Expansion 90
12.3.5 Other Organic Strategies 91
12.4 INORGANIC GROWTH STRATEGIES 92
12.4.1 Overview 92
12.4.2 Partnerships 92
12.4.3 Collaborations 93
12.4.4 Agreements 94
12.4.5 Acquisitions 94
12.4.6 Other Inorganic Strategies 95
13. ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET – KEY COMPANY PROFILES 96
13.1 DEFYMED 96
13.1.1 Key Facts 96
13.1.2 Business Description 96
13.1.3 Financial Overview 96
13.1.4 Product Pipeline 97
13.1.5 Swot Analysis 97
13.1.6 Key Developments 97
13.2 TYPEZERO TECHNOLOGIES, INC. 98
13.2.1 Key Facts 98
13.2.2 Business Description 98
13.2.3 Financial Overview 98
13.2.4 Product Pipeline 98
13.2.5 SWOT Analysis 99
13.2.6 Key Developments 99
13.3 INSULET CORPORATION 100
13.3.1 Key Facts 100
13.3.2 Business Description 100
13.3.3 Financial Information 101
13.3.4 Product Pipeline 101
13.3.5 SWOT Analysis 102
13.3.6 Key Developments 102
13.4 BIGFOOT BIOMEDICAL, INC. 103
13.4.1 Key Facts 103
13.4.2 Business Description 103
13.4.3 Financial Information 103
13.4.4 Product Pipeline 103
13.4.5 SWOT Analysis 104
13.4.6 Key Developments 104
13.5 MEDTRONIC 105
13.5.1 Key Facts 105
13.5.2 Business Description 105
13.5.3 Financial Information 106
13.5.4 Product Portfolio 106
13.5.5 SWOT Analysis 107
13.5.6 Key Developments 107
13.6 DEXCOM, INC. 109
13.6.1 Key Facts 109
13.6.2 Business Description 109
13.6.3 Financial Overview 110
13.6.4 Product Portfolio 110
13.6.5 Swot Analysis 111
13.6.6 Key Developments 111
13.7 ADMETSYS 113
13.7.1 Key Facts 113
13.7.2 Business Description 113
13.7.3 Financial Overview 113
13.7.4 Product Pipeline 113
13.7.5 SWOT Analysis 114
13.7.6 Key Developments 114
13.8 BETA BIONICS 115
13.8.1 Key Facts 115
13.8.2 Business Description 115
13.8.3 Financial Overview 115
13.8.4 Product Pipeline 115
13.8.5 SWOT Analysis 116
13.8.6 Key Developments 116
13.9 CELLNOVO 117
13.9.1 Key Facts 117
13.9.2 Business Description 117
13.9.3 Financial Overview 117
13.9.4 Product Portfolio 118
13.9.5 Product Pipeline 118
13.9.6 SWOT Analysis 118
13.9.7 Key Developments 118
13.10 TANDEM DIABETES CARE, INC. 120
13.10.1 Key Facts 120
13.10.2 Business Description 120
13.10.3 Financial Information 120
13.10.4 Product Pipeline 121
13.10.5 SWOT Analysis 121
13.10.6 Key Developments 121
14. APPENDIX 123
14.1 ABOUT THE INSIGHT PARTNERS 123
14.2 GLOSSARY OF TERMS 124
14.3 METHODOLOGY 126
14.3.1 Coverage 127
14.3.2 Secondary Research 128
14.3.3 Primary Research 128
LIST OF TABLES
TABLE 1. PREVALENCE OF DIABETES ACROSS THE GLOBE, 2017 33
TABLE 2. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 48
TABLE 3. US ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 51
TABLE 4. CANADA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 53
TABLE 5. MEXICO ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 55
TABLE 6. EUROPE ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 57
TABLE 7. GERMANY ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 60
TABLE 8. UK ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 62
TABLE 9. FRANCE ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 64
TABLE 10. ASIA PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 66
TABLE 11. ASIA PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (US$ MN) 67
TABLE 12. JAPAN ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 69
TABLE 13. CHINA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 71
TABLE 14. INDIA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 73
TABLE 15. MIDDLE EAST AND AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 75
TABLE 16. MIDDLE EAST AND AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (US$ MN) 76
TABLE 17. UAE ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 78
TABLE 18. SAUDI ARABIA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 80
TABLE 19. SOUTH AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 82
TABLE 20. SOUTH AND CENTRAL AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 84
TABLE 21. BRAZIL ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025, BY TYPE (US$ MN) 87
TABLE 22. RECENT PRODUCT APPROVALS IN THE ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET 89
TABLE 23. RECENT PRODUCT LAUNCHES IN THE ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET 90
TABLE 24. RECENT EXPANSIONS IN THE ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET 90
TABLE 25. RECENT OTHER ORGANIC STRATEGIES IN THE ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET 91
TABLE 26. RECENT PARTNERSHIPS & COLLABORATIONS IN THE ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET 92
TABLE 27. RECENT COLLABORATIONS IN THE ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET 93
TABLE 28. RECENT AGREEMENTS IN THE ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET 94
TABLE 29. RECENT ACQUISITIONS IN THE ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET 94
TABLE 30. RECENT OTHER INORAGNIC STRATEGIES IN THE ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET 95
TABLE 31. GLOSSARY OF TERMS, ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET 124
LIST OF FIGURES
FIGURE 1. ASIA PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET, REVENUE (US$ MN), BY GEOGRAPHY 2018 & 2025 17
FIGURE 2. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET BY TYPE, MARKET SHARE (%), 2017 18
FIGURE 3. ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET SEGMENTATION 19
FIGURE 4. ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET SEGMENTATION, BY REGION 20
FIGURE 5. NORTH AMERICA PEST ANALYSIS 22
FIGURE 6. EUROPE PEST ANALYSIS 24
FIGURE 7. ASIA PACIFIC PEST ANALYSIS 26
FIGURE 8. MIDDLE EAST AND AFRICA PEST ANALYSIS 28
FIGURE 9. SOUTH AND CENTRAL AMERICA PEST ANALYSIS 30
FIGURE 10. ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET IMPACT ANALYSIS OF DRIVER AND RESTRAINTS 38
FIGURE 11. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET – REVENUE FORECASTS AND ANALYSIS – 2017- 2025 39
FIGURE 12. GLOBAL ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET – BY GEOGRAPHY FORECASTS AND ANALYSIS – 2017- 2025 40
FIGURE 13. GLOBAL ARTIFICIAL PANCREAS DEVICES SYSTEMS MARKET, BY TYPE, 2017 & 2025 (%) 43
FIGURE 14. GLOBAL CONTROL TO RANGE MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 44
FIGURE 15. GLOBAL CONTROL TO TARGET MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 45
FIGURE 16. GLOBAL THRESHOLD SUSPENDED DEVICE SYSTEM MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 46
FIGURE 17. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET OVERVIEW, BY COUNTRY (2017) 47
FIGURE 18. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 48
FIGURE 19. NORTH AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 49
FIGURE 20. US ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 51
FIGURE 21. CANADA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 52
FIGURE 22. MEXICO ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 54
FIGURE 23. EUROPE ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET SHARE OVERVIEW, BY COUNTRY (2017) (%) 56
FIGURE 24. EUROPE ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 57
FIGURE 25. EUROPE ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025, BY COUNTRY (%) 58
FIGURE 26. GERMANY ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 60
FIGURE 27. UK ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 61
FIGURE 28. FRANCE ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 63
FIGURE 29. ASIA PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET OVERVIEW, BY COUNTRY (2017) 65
FIGURE 30. ASIA PACIFIC ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 66
FIGURE 31. JAPAN ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 69
FIGURE 32. CHINA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 70
FIGURE 33. INDIA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 73
FIGURE 34. MIDDLE EAST AND AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET OVERVIEW, BY COUNTRY (2017) 74
FIGURE 35. MIDDLE EAST AND AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 75
FIGURE 36. UAE ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 78
FIGURE 37. SAUDI ARABIA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 80
FIGURE 38. SOUTH AFRICA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 82
FIGURE 39. SOUTH AND CENTRAL AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET OVERVIEW, BY COUNTRY (2017) 83
FIGURE 40. SOUTH AND CENTRAL AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 84
FIGURE 41. SOUTH AND CENTRAL AMERICA ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET SHARE, BY COUNTRY (2017 & 2025) (%) 85
FIGURE 42. BRAZIL ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET REVENUE AND FORECASTS TO 2025 (US$ MN) 86
FIGURE 43. GROWTH STRATEGIES IN THE ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET, 2016-2018 88
FIGURE 44. ORGANIC GROWTH STRATEGIES IN THE ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET, 2016-2018 89
FIGURE 45. INORGANIC GROWTH STRATEGIES IN THE ARTIFICIAL PANCREAS DEVICE SYSTEMS MARKET, 2016-2018 92
The List of Companies
- Defymed
- TypeZero Technologies, Inc.
- Insulet Corporation
- Bigfoot Biomedical, Inc.
- Medtronic
- Dexcom, Inc.
- Admetsys
- Beta Bionics
- Cellnovo
- Tandem Diabetes Care
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For